Hainan Poly Pharm (300630.SZ): Busulfex injection granted temporary approval by the US FDA.
PulicPharma (300630.SZ) announced that the company recently received a notification from the U.S. Food and Drug Administration (FDA)...
Hainan Poly Pharm (300630.SZ) announced that the company recently received temporary approval from the Food and Drug Administration (FDA) of the United States for the injection of Brivudine. The indication for this drug is the treatment of partial onset seizures in patients aged 1 month and older.
Related Articles
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.
JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.
ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
RECOMMEND
Jensen Huang Confirms NVIDIA to Begin H20 Chip Shipments to China
15/07/2025
Manus Exits China Market Amid $500 Million Valuation, Prompting Concerns Over AI Agent Sector Outlook
15/07/2025
Trump to Allocate $70 Billion in AI and Energy Investment, Escalating the Race for Technological Dominance
15/07/2025
